Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course.

van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, Bol SM, Burger JA, Zwinderman AH, Moerland PD, van 't Slot R, Zagury JF, van 't Wout AB, Schuitemaker H.

PLoS One. 2011;6(7):e22208. doi: 10.1371/journal.pone.0022208. Epub 2011 Jul 21.

2.

Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.

van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, Schuitemaker H.

AIDS. 2009 Jan 2;23(1):19-28. doi: 10.1097/QAD.0b013e32831db247. Erratum in: AIDS. 2010 Mar 27;24(6):939.

PMID:
19050382
3.

Identification of IL7RA risk alleles for rapid progression during HIV-1 infection: a comprehensive study in the GRIV cohort.

Limou S, Melica G, Coulonges C, Lelièvre JD, Do H, McGinn S, Gut IG, Lévy Y, Zagury JF.

Curr HIV Res. 2012 Mar;10(2):143-50.

PMID:
22329520
4.

Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.

Touloumi G, Karafoulidou A, Gialeraki A, Katsarou O, Milona I, Kapsimali V, Mandalaki T, Hatzakis A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):89-97.

PMID:
9732075
5.

HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.

Rachinger A, Kootstra NA, Gijsbers EF, van den Kerkhof TL, Schuitemaker H, van 't Wout AB.

AIDS. 2012 Jul 31;26(12):1517-22. doi: 10.1097/QAD.0b013e328354f539.

PMID:
22555160
6.

Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.

Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI.

J Infect Dis. 2010 Feb 15;201(4):618-26. doi: 10.1086/649842.

7.

Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.

Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35. doi: 10.1097/QAI.0b013e318184fb41.

PMID:
18769358
8.

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, Rucart P, Sandhu MS, Shea PR, Schuitemaker H, Theodorou I, Vannberg F, Veldink J, Walker BD, Weintrob A, Winkler CA, Wolinsky S, Telenti A, Goldstein DB, de Bakker PI, Zagury JF, Fellay J.

PLoS Pathog. 2013;9(7):e1003515. doi: 10.1371/journal.ppat.1003515. Epub 2013 Jul 25.

9.

Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Veloso S, Olona M, García F, Domingo P, Alonso-Villaverde C, Broch M, Peraire J, Viladés C, Plana M, Pedrol E, López-Dupla M, Aguilar C, Gutiérrez M, Leon A, Tasias M, Gatell JM, Richart C, Vidal F.

BMC Med Genet. 2010 Apr 26;11:63. doi: 10.1186/1471-2350-11-63.

10.

A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.

Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, John M, Haas DW, Martinez-Picado J, Dalmau J, López-Galíndez C, Casado C, Rauch A, Günthard HF, Bernasconi E, Vernazza P, Klimkait T, Yerly S, O'Brien SJ, Listgarten J, Pfeifer N, Lippert C, Fusi N, Kutalik Z, Allen TM, Müller V, Harrigan PR, Heckerman D, Telenti A, Fellay J.

Elife. 2013 Oct 29;2:e01123. doi: 10.7554/eLife.01123.

11.

ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression.

Ballana E, Senserrich J, Pauls E, Faner R, Mercader JM, Uyttebroeck F, Palou E, Mena MP, Grau E, Clotet B, Ruiz L, Telenti A, Ciuffi A, Esté JA.

Clin Infect Dis. 2010 Apr 1;50(7):1022-32. doi: 10.1086/651114.

PMID:
20192730
12.

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.

Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, Deveau C, Boufassa F, Debré P, Delfraissy JF, Broet P, Theodorou I; ANRS Genome Wide Association 01.

PLoS One. 2008;3(12):e3907. doi: 10.1371/journal.pone.0003907. Epub 2008 Dec 24.

13.

Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.

Rits MA, van Dort KA, Kootstra NA.

PLoS One. 2008;3(12):e3975. doi: 10.1371/journal.pone.0003975. Epub 2008 Dec 18.

14.

Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

N Engl J Med. 2012 Jul 19;367(3):224-32. doi: 10.1056/NEJMoa1113244.

15.

Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.

Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F.

AIDS. 1997 Sep;11(11):1383-8.

PMID:
9302449
16.

Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.

Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, Spector SA.

J Infect Dis. 2003 Nov 15;188(10):1461-72. Epub 2003 Nov 18.

PMID:
14624371
17.

Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.

Suligoi B, Dorrucci M, Uccella I, Andreoni M, Rezza G; Italian Seroconversion Study.

J Med Virol. 2003 Feb;69(2):182-7.

PMID:
12683405
18.

Evidence after imputation for a role of MICA variants in nonprogression and elite control of HIV type 1 infection.

Le Clerc S, Delaneau O, Coulonges C, Spadoni JL, Labib T, Laville V, Ulveling D, Noirel J, Montes M, Schächter F, Caillat-Zucman S, Zagury JF.

J Infect Dis. 2014 Dec 15;210(12):1946-50. doi: 10.1093/infdis/jiu342. Epub 2014 Jun 16.

PMID:
24939907
19.

Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans.

Bigham AW, Mackelprang RD, Celum C, De Bruyn G, Beima-Sofie K, John-Stewart G, Ronald A, Mugo NR, Buckingham K, Bamshad MJ, Mullins JI, McElrath MJ, Lingappa JR.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):127-34. doi: 10.1097/QAI.0000000000000113.

20.

Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.

Lyles CM, Graham NM, Astemborski J, Vlahov D, Margolick JB, Saah AJ, Farzadegan H.

Eur J Epidemiol. 1999 Feb;15(2):99-108.

PMID:
10204638

Supplemental Content

Support Center